EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vincristine‐Induced Unilateral Foot Drop in a Patient With Diffuse Large B‐Cell Lymphoma: A Rare Presentation of Severe Motor Axonopathy

Nishchal Regmi iD, Prashant Pant, Umang Gupta, Mipsang Lama

Clinical Case Reports · 2026-03 · 14 (3)

DOI: 10.1002/ccr3.72283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 15.03.2026. Verfasst von Nishchal Regmi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Patan Academy of Health Sciences Lalitpur Nepal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vincristine is a cornerstone chemotherapeutic agent in combination regimens for lymphoid malignancies; however, its neurotoxicity remains a major dose‐limiting adverse effect. While vincristine‐induced peripheral neuropathy (VIPN) commonly presents as a symmetric, sensory‐predominant polyneuropathy, isolated unilateral motor neuropathy causing foot drop is exceedingly rare. We report a case of a 64‐year‐old male with extranodal diffuse large B‐cell lymphoma (DLBCL) of the left calf muscle, staged as Ann Arbor stage IE with Revised International Prognostic Index (R‐IPI) score of 2, who developed left‐sided foot drop following the second cycle of dose‐adjusted R‐DA‐EPOCH chemotherapy. Neurological examination confirmed isolated left peroneal nerve palsy with mild sensory involvement, and nerve conduction studies revealed motor axonal neuropathy consistent with vincristine toxicity. MRI excluded local compressive or infiltrative pathology and demonstrated interval tumor response. Vincristine dosing did not exceed the capped dose of 2 mg during the first two cycles; from the third cycle onward, the dose was reduced by approximately 60%. Early physiotherapy, ankle‐foot orthosis support, and symptomatic pharmacologic therapy were initiated, leading to gradual neurological recovery. This case highlights the importance of early recognition of vincristine‐induced neuropathy and timely dose adjustment to prevent irreversible deficits while maintaining therapeutic efficacy.

Schlagwörter

Stichwörter der Autor:innen

chemotherapy‐induced neurotoxicitydiffuse large B‐cell lymphomafoot dropmotor axonopathyvincristine

Autor:innen und Institutionen

  • Department of Internal Medicine Patan Academy of Health Sciences Lalitpur Nepal.
  • Palisades Medical Center Hackensack Meridian Health North Bergen New Jersey USA.
  • Department of Hematology Patan Academy of Health Sciences Lalitpur Nepal.

ORCID-Profile: Nishchal Regmi

Zitieren

APA

Regmi, N., Pant, P., Gupta, U., & Lama, M. (2026). Vincristine‐Induced Unilateral Foot Drop in a Patient With Diffuse Large B‐Cell Lymphoma: A Rare Presentation of Severe Motor Axonopathy. Clinical Case Reports, 14(3). https://doi.org/10.1002/ccr3.72283

Vancouver

Regmi N, Pant P, Gupta U, Lama M. Vincristine‐Induced Unilateral Foot Drop in a Patient With Diffuse Large B‐Cell Lymphoma: A Rare Presentation of Severe Motor Axonopathy. Clinical Case Reports. 2026;14(3). doi:10.1002/ccr3.72283

BibTeX
@article{Regmi2026,
  author = {Regmi, Nishchal and Pant, Prashant and Gupta, Umang and Lama, Mipsang},
  title = {Vincristine‐Induced Unilateral Foot Drop in a Patient With Diffuse Large B‐Cell Lymphoma: A Rare Presentation of Severe Motor Axonopathy},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/ccr3.72283}
}
Kostenlos starten →